www.chemicalsknowledgehub.com
automated monitoring and artificial intelligence can mitigate this by providing real-time information on all aspects of drug manufacture. This will not only help to increase efficiency by reducing the time spent investigating the cause of any issues that arise, but will also reassure manufacturers that the drugs fully meet all of the stringent GMP regulations set out. [3,4]
Continuous manufacturing paves the way for the personalized medicine revolution
As researchers continue to expand our knowledge of how an individual’s molecular biology influences their response to a given drug, personalized medicine opens up new horizons for the medical field. In an industry accustomed to producing drugs on a large scale for widespread use, however, continuous manufacturing, combined with advances in AI and automation, has emerged as a solution to the practical challenges associated with manufacturing customized therapies on a small scale. By offering chemical
Life Sciences Focus: Process Development
engineers the flexibility to adjust production to meet demand, access new synthetic routes and continuously monitor quality, in the future it is expected that the technology will continue to establish itself in Pharma, helping patients obtain access to vital treatments.
REFERENCES
1.https://
www.phcal-journal.com/ your-rps/what-impact-will-personalised- medicine-have-on-pharmacy/20201328 article?firstPass=false 2.
https://www.su haindive.com/news/ personalized-medicine-cold-chain- logistics-growth/434060/ 3.
https://www.phceutical-technology.com/ contractors/machines-labelling/dividella2/
pressreleases/pharma-4-0-enabling- factory-future/ 4.
https://www.pharmaceutical
processingworld.com/pharma-4-0 -industry-4-0-applied-to-pharmaceutical -manufacturing/
Author:
Dr Gareth Jenkins, CSO, Arcinova E:
info@arcinova.com
FLOW CHEMISTRY
ü R&D, SCALE-UP AND MANUFACTURING ü FDA INSPECTED ü GMP ü PROVEN MANUFACTURING EXPERIENCE ü SCALE-UP EXPERTISE ü ROBUST CHEMISTRY DESIGN ü ENZYMATIC TRANSFORMATIONS IN FLOW
Contact:
Stephen.Drake@kaneka.com. Summer 2020 Visit:
www.Kaneka.co.jp 23
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60
